June 12, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: How stereo-correct data can de-risk AI-driven drug discovery
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > How stereo-correct data can de-risk AI-driven drug discovery
Drug development

How stereo-correct data can de-risk AI-driven drug discovery

By Newsroom
Last updated: October 19, 2025
1 Min Read
Share


Image: Wikimedia Commons (Public Domain)

Image: Wikimedia Commons (Public Domain)

In drug discovery, the difference between a breakthrough and a breakdown can be as small as the twist of a bond. Stereochemistry, the three-dimensional arrangement of atoms, governs how otherwise identical molecules behave in the body: whether they bind the intended target, trigger off-targets, or get cleared in minutes rather than hours.

Adam Sanford

Adam Sanford, Ph.D.

“Shape really does matter,” said Adam Sanford, Ph.D., senior product lead at scientific…



Source link

TAGGED:AI drug designchiralitycomputational chemistrydata qualityDrug discoveryenantiomersFDA approvalMachine Learningmolecular modelingQSARstereochemistrythalidomide
Share This Article
Facebook Email Copy Link Print

HOT NEWS

Manitoba pledges $24M for rural water, wastewater infrastructure

Environmental Science
April 19, 2025

20 ChatGPT Prompts That Rewire How You Think and Act ($21…

Learn 20 ChatGPT prompts for personal development including life planning, habit design, mental clarity, discipline…

June 11, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Xaira taps scGPT pioneer Bo Wang to lead biomedical AI

Bo Wang, Ph.D., is a Xairanaut. That is, he’s the latest high-profile scientific leader to join the unicorn Xaira Therapeutics,…

Drug development
April 5, 2025

QSP Modeling | Preclinical Radiopharmaceuticals Development

The preclinical-to-clinical transition remains a major bottleneck for targeted radiotherapies due to their complexity and novelty. Traditional dosimetry translation methods…

Drug development
November 16, 2025

This week in Drug Discovery (9 – 13 February) 

News round-up for 9 – 13 February by Bruno Quinney, Content Team at DDW. This week in DDW, researchers have made a key discovery into…

Drug development
February 15, 2026

Pfizer sues Novo Nordisk and Metsera in bidding war

Pfizer has filed two lawsuits against the metabolic-focused startup Metsera and Novo Nordisk as of Tuesday. The first suit, filed…

Drug development
November 9, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

20 ChatGPT Prompts That Rewire How You Think and Act ($21…
June 11, 2026
The GPT-5.5 Release Explained: What Changed and How to Use It…
June 11, 2026
The Front-End Shift
June 11, 2026
Practical Considerations for Your Sub-Contracted Process…
June 11, 2026

Life Science Magazines

20 ChatGPT Prompts That Rewire How You Think and Act ($21…
June 11, 2026
The GPT-5.5 Release Explained: What Changed and How to Use It…
June 11, 2026
The Front-End Shift
June 11, 2026
Practical Considerations for Your Sub-Contracted Process…
June 11, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?